- call +1-201-465-4211
- email sales@mrinsights.biz
Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time.
Scope of the Report:
The global Point of Care Diagnostics (POCD) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Point of Care Diagnostics (POCD).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Point of Care Diagnostics (POCD) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Point of Care Diagnostics (POCD) market by product type and applications/end industries.
Market Segment by Companies, this report covers
Roche
Abbott
BioMérieux
Abaxis
Siemens Healthineers
QIAGEN
Danaher
Instrumentation Laboratory
Nova Biomedical
Quidel
Trinity Biotech
Sekisui Diagnostics
OraSure Technologies
Johnson & Johnson
Becton Dickinson
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Glucose Testing
Hb1Ac Testing
Infectious Disease Testing
Coagulation
Fertility
Cardiac markers
Primary care systems
Hematology
Decentralized Clinical Chemistry
Feces
Market Segment by Applications, can be divided into
Clinics
Hospitals
Assisted Living Healthcare Facilities
Laboratory
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Point of Care Diagnostics (POCD) Market Overview
1.1 Product Overview and Scope of Point of Care Diagnostics (POCD)
1.2 Classification of Point of Care Diagnostics (POCD) by Types
1.2.1 Global Point of Care Diagnostics (POCD) Revenue Comparison by Types (2017-2023)
1.2.2 Global Point of Care Diagnostics (POCD) Revenue Market Share by Types in 2017
1.2.3 Glucose Testing
1.2.4 Hb1Ac Testing
1.2.5 Infectious Disease Testing
1.2.6 Coagulation
1.2.7 Fertility
1.2.8 Cardiac markers
1.2.9 Primary care systems
1.2.10 Hematology
1.2.11 Decentralized Clinical Chemistry
1.2.12 Feces
1.3 Global Point of Care Diagnostics (POCD) Market by Application
1.3.1 Global Point of Care Diagnostics (POCD) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Assisted Living Healthcare Facilities
1.3.5 Laboratory
1.4 Global Point of Care Diagnostics (POCD) Market by Regions
1.4.1 Global Point of Care Diagnostics (POCD) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Point of Care Diagnostics (POCD) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Point of Care Diagnostics (POCD) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Point of Care Diagnostics (POCD) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Point of Care Diagnostics (POCD) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Point of Care Diagnostics (POCD) Status and Prospect (2013-2023)
1.5 Global Market Size of Point of Care Diagnostics (POCD) (2013-2023)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Point of Care Diagnostics (POCD) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott
2.2.1 Business Overview
2.2.2 Point of Care Diagnostics (POCD) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.3 BioMérieux
2.3.1 Business Overview
2.3.2 Point of Care Diagnostics (POCD) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioMérieux Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abaxis
2.4.1 Business Overview
2.4.2 Point of Care Diagnostics (POCD) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abaxis Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Siemens Healthineers
2.5.1 Business Overview
2.5.2 Point of Care Diagnostics (POCD) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Siemens Healthineers Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.6 QIAGEN
2.6.1 Business Overview
2.6.2 Point of Care Diagnostics (POCD) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 QIAGEN Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Danaher
2.7.1 Business Overview
2.7.2 Point of Care Diagnostics (POCD) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Danaher Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.8 Instrumentation Laboratory
2.8.1 Business Overview
2.8.2 Point of Care Diagnostics (POCD) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Nova Biomedical
2.9.1 Business Overview
2.9.2 Point of Care Diagnostics (POCD) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nova Biomedical Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.10 Quidel
2.10.1 Business Overview
2.10.2 Point of Care Diagnostics (POCD) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Quidel Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.11 Trinity Biotech
2.11.1 Business Overview
2.11.2 Point of Care Diagnostics (POCD) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Trinity Biotech Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.12 Sekisui Diagnostics
2.12.1 Business Overview
2.12.2 Point of Care Diagnostics (POCD) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.13 OraSure Technologies
2.13.1 Business Overview
2.13.2 Point of Care Diagnostics (POCD) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 OraSure Technologies Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.14 Johnson & Johnson
2.14.1 Business Overview
2.14.2 Point of Care Diagnostics (POCD) Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Johnson & Johnson Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
2.15 Becton Dickinson
2.15.1 Business Overview
2.15.2 Point of Care Diagnostics (POCD) Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Becton Dickinson Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2016-2017)
3 Global Point of Care Diagnostics (POCD) Market Competition, by Players
3.1 Global Point of Care Diagnostics (POCD) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Point of Care Diagnostics (POCD) Players Market Share
3.2.2 Top 10 Point of Care Diagnostics (POCD) Players Market Share
3.3 Market Competition Trend
4 Global Point of Care Diagnostics (POCD) Market Size by Regions
4.1 Global Point of Care Diagnostics (POCD) Revenue and Market Share by Regions
4.2 North America Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
4.3 Europe Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
4.5 South America Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
5 North America Point of Care Diagnostics (POCD) Revenue by Countries
5.1 North America Point of Care Diagnostics (POCD) Revenue by Countries (2013-2018)
5.2 USA Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
5.3 Canada Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
5.4 Mexico Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
6 Europe Point of Care Diagnostics (POCD) Revenue by Countries
6.1 Europe Point of Care Diagnostics (POCD) Revenue by Countries (2013-2018)
6.2 Germany Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
6.3 UK Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
6.4 France Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
6.5 Russia Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
6.6 Italy Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Point of Care Diagnostics (POCD) Revenue by Countries
7.1 Asia-Pacific Point of Care Diagnostics (POCD) Revenue by Countries (2013-2018)
7.2 China Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
7.3 Japan Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
7.4 Korea Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
7.5 India Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
8 South America Point of Care Diagnostics (POCD) Revenue by Countries
8.1 South America Point of Care Diagnostics (POCD) Revenue by Countries (2013-2018)
8.2 Brazil Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
8.3 Argentina Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
8.4 Colombia Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Point of Care Diagnostics (POCD) by Countries
9.1 Middle East and Africa Point of Care Diagnostics (POCD) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
9.3 UAE Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
9.4 Egypt Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
9.6 South Africa Point of Care Diagnostics (POCD) Revenue and Growth Rate (2013-2018)
10 Global Point of Care Diagnostics (POCD) Market Segment by Type
10.1 Global Point of Care Diagnostics (POCD) Revenue and Market Share by Type (2013-2018)
10.2 Global Point of Care Diagnostics (POCD) Market Forecast by Type (2018-2023)
10.3 Glucose Testing Revenue Growth Rate (2013-2023)
10.4 Hb1Ac Testing Revenue Growth Rate (2013-2023)
10.5 Infectious Disease Testing Revenue Growth Rate (2013-2023)
10.6 Coagulation Revenue Growth Rate (2013-2023)
10.7 Fertility Revenue Growth Rate (2013-2023)
10.8 Cardiac markers Revenue Growth Rate (2013-2023)
10.9 Primary care systems Revenue Growth Rate (2013-2023)
10.10 Hematology Revenue Growth Rate (2013-2023)
10.11 Decentralized Clinical Chemistry Revenue Growth Rate (2013-2023)
10.12 Feces Revenue Growth Rate (2013-2023)
11 Global Point of Care Diagnostics (POCD) Market Segment by Application
11.1 Global Point of Care Diagnostics (POCD) Revenue Market Share by Application (2013-2018)
11.2 Point of Care Diagnostics (POCD) Market Forecast by Application (2018-2023)
11.3 Clinics Revenue Growth (2013-2018)
11.4 Hospitals Revenue Growth (2013-2018)
11.5 Assisted Living Healthcare Facilities Revenue Growth (2013-2018)
11.6 Laboratory Revenue Growth (2013-2018)
12 Global Point of Care Diagnostics (POCD) Market Size Forecast (2018-2023)
12.1 Global Point of Care Diagnostics (POCD) Market Size Forecast (2018-2023)
12.2 Global Point of Care Diagnostics (POCD) Market Forecast by Regions (2018-2023)
12.3 North America Point of Care Diagnostics (POCD) Revenue Market Forecast (2018-2023)
12.4 Europe Point of Care Diagnostics (POCD) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Point of Care Diagnostics (POCD) Revenue Market Forecast (2018-2023)
12.6 South America Point of Care Diagnostics (POCD) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Point of Care Diagnostics (POCD) Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Point of Care Diagnostics (POCD) Picture
Table Product Specifications of Point of Care Diagnostics (POCD)
Table Global Point of Care Diagnostics (POCD) and Revenue (
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
